1. National Cancer Institute (2015). SEER Cancer Statistics Factsheets: Prostate Cancer.
http://seer.cancer.gov/statfacts/html/prost.html
.
2. American Cancer Society (2015). Prostate Cancer Overview.
http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-what-is-prostate-cancer
.
3. Wilt, T. J., MacDonald, R., Rutks, I., Shamliyan, T. A., Taylor, B. C., & Kane, R. L. (2008). Systematic review: Comparative effectiveness and harms of treatments for clinically localized prostate cancer. Annals of Internal Medicine,
148(6), 435–448. doi:
10.7326/0003-4819-148-6-200803180-00209
.
4. Xiong, T., Turner, R. M., Wei, Y., Neal, D. E., Lyratzopoulos, G., & Higgins, J. P. (2014). Comparative efficacy and safety of treatments for localised prostate cancer: An application of network meta-analysis. BMJ Open,
4(5), e004285. doi:
10.1136/bmjopen-2013-004285
.
5. Sun F, Oyesanmi O, Fontanarosa J, Reston J, Guzzo T, & Schoelles K (December 2014). Therapies for Clinically Localized Prostate Cancer: Update of a 2008 Systematic Review. Comparative Effectiveness Review No. 146. (Prepared by the ECRI Institute–Penn Medicine Evidence-based Practice Center under Contract No. 290-2007-10063.) AHRQ Publication No. 15-EHC004-EF. Rockville, MD: Agency for Healthcare Research and Quality.